Novartis is acquiring a biotechnology company whose core is made up of a team of Greek scientists, for $1.7 billion. By May 5, 2025 Author: Post navigationPreviousPrevious post:ATHEX: Small gains despite drop by EurobankNextNext post:German climber injured in Mt. Olympus fall
